Ambria Dermatology
Helsingborg
About Ambria Dermatology
Ambria Dermatology AB, a research and development company, focuses on solutions in dermatology science. It offers technology platform, which includes pentane-1,5-diol delivery platform for the dermal delivery of topically applied pharmaceuticals, cosmeceuticals, and products for technical use. The company is based in Helsingborg, Sweden. As of October 30, 2009, Ambria Dermatology AB operates as a subsidiary of Natumin Pharma AB.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $705.7K
- Last round: Series Unknown (Nov 2006)
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/ambria-dermatology-265319 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.